Metraipolis › archive › dc_504701ac16ca

Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus… — Europe PMC PMID:42056378

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42056378
DOI: 10.1038/s41416-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-11-03T01:43:11.472Z
SHA-256 of the archived text: cb4b2d0263cec492c1dda89905d7001a79920a4044db9d043db6bf03d3e3829e
Stable URL of this page: https://metraipolis.com/documento/dc_504701ac16ca

How to cite

Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus… — Europe PMC PMID:42056378 — Europe PMC (en), https://europepmc.org/article/MED/42056378 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_504701ac16ca (Metraipolis archive dc_504701ac16ca, sha256 cb4b2d0263cec492c1dda89905d7001a79920a4044db9d043db6bf03d3e3829e)

BibTeX

@misc{dc504701ac16ca,
  title = {Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus… — Europe PMC PMID:42056378},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42056378},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_504701ac16ca; sha256 cb4b2d0263cec492c1dda89905d7001a79920a4044db9d043db6bf03d3e3829e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42056378. Agents can read the archived copy with the MCP tool read_document.